ASX - By Stock
|
OCC |
Re:
Mkt Cap n small trades
|
|
FShannon
|
3 |
1.0K |
4 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
3
|
1.0K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
4 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
4
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Quarterly Activities Report
|
|
FShannon
|
28 |
11K |
3 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
28
|
11K
|
3
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Quarterly Activities Report
|
|
FShannon
|
28 |
11K |
28 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
28
|
11K
|
28
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Quarterly Activities Report
|
|
FShannon
|
28 |
11K |
21 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
28
|
11K
|
21
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Quarterly Activities Report
|
|
FShannon
|
28 |
11K |
11 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
28
|
11K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
FShannon
|
197 |
34K |
8 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
197
|
34K
|
8
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
FShannon
|
3.0K |
1.1M |
6 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
3.0K
|
1.1M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
FShannon
|
19K |
6.5M |
20 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
19K
|
6.5M
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust and WEHI to Investigate HTLV-1 Viral Infections
|
|
FShannon
|
42 |
11K |
5 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
42
|
11K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42X patent update & open label extension study approval
|
|
FShannon
|
200 |
56K |
1 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
200
|
56K
|
1
|
|
ASX - By Stock
|
FGR |
Re:
It's starting
|
|
FShannon
|
27 |
14K |
5 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
27
|
14K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42X patent update & open label extension study approval
|
|
FShannon
|
200 |
56K |
18 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
200
|
56K
|
18
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42X patent update & open label extension study approval
|
|
FShannon
|
200 |
56K |
8 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
200
|
56K
|
8
|
|
ASX - By Stock
|
FGR |
Re:
This Stock
|
|
FShannon
|
13 |
5.0K |
16 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
13
|
5.0K
|
16
|
|
ASX - By Stock
|
FGR |
Re:
This Stock
|
|
FShannon
|
13 |
5.0K |
2 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
13
|
5.0K
|
2
|
|
ASX - By Stock
|
FGR |
Re:
This Stock
|
|
FShannon
|
13 |
5.0K |
17 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
13
|
5.0K
|
17
|
|
ASX - By Stock
|
FGR |
Re:
Gerdau
|
|
FShannon
|
140 |
53K |
6 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
140
|
53K
|
6
|
|
ASX - By Stock
|
FGR |
Re:
Steel Blue
|
|
FShannon
|
40 |
10K |
1 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
40
|
10K
|
1
|
|
ASX - By Stock
|
FGR |
Re:
Steel Blue
|
|
FShannon
|
40 |
10K |
5 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
40
|
10K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
5 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
5
|
|
ASX - By Stock
|
FGR |
Re:
Steel Blue
|
|
FShannon
|
40 |
10K |
5 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
40
|
10K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
7 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
7
|
|
ASX - By Stock
|
FGR |
Re:
Steel Blue
|
|
FShannon
|
40 |
10K |
3 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
40
|
10K
|
3
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Functionalised Graphene
|
|
FShannon
|
26 |
9.9K |
2 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
26
|
9.9K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
FShannon
|
19K |
6.5M |
3 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
19K
|
6.5M
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
FShannon
|
1.6K |
476K |
2 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
1.6K
|
476K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Positive CelGro Nerve Regeneration Results
|
|
FShannon
|
79 |
22K |
5 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
79
|
22K
|
5
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Functionalised Graphene
|
|
FShannon
|
26 |
9.9K |
5 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
26
|
9.9K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Industry news
|
|
FShannon
|
898 |
358K |
11 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
898
|
358K
|
11
|
|
ASX - By Stock
|
FGR |
Re:
Frustrating Stock
|
|
FShannon
|
28 |
8.3K |
1 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
28
|
8.3K
|
1
|
|
ASX - By Stock
|
FGR |
Re:
Frustrating Stock
|
|
FShannon
|
28 |
8.3K |
6 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
28
|
8.3K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
FShannon
|
1.6K |
476K |
4 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
1.6K
|
476K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
US Govt $US3B for oral therapies
|
|
FShannon
|
9 |
2.1K |
10 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
9
|
2.1K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
FShannon
|
2.0K |
1.0M |
7 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
2.0K
|
1.0M
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
FShannon
|
732 |
144K |
5 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
732
|
144K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
FShannon
|
732 |
144K |
6 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
732
|
144K
|
6
|
|
ASX - By Stock
|
FGR |
Re:
Frustrating Stock
|
|
FShannon
|
28 |
8.3K |
11 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
28
|
8.3K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
FShannon
|
1.6K |
476K |
3 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
1.6K
|
476K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
6 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
2 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
2
|
|
ASX - By Stock
|
FGR |
Re:
Frustrating Stock
|
|
FShannon
|
28 |
8.3K |
3 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
28
|
8.3K
|
3
|
|
ASX - By Stock
|
FGR |
Re:
Ann: FGR Launches PureGRAPH LDPE
|
|
FShannon
|
17 |
6.0K |
6 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
17
|
6.0K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
8 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
8
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Functionalised Graphene
|
|
FShannon
|
26 |
9.9K |
5 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
26
|
9.9K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
2 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
2
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Functionalised Graphene
|
|
FShannon
|
26 |
9.9K |
6 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
26
|
9.9K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
FShannon
|
8.4K |
3.1M |
5 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
8.4K
|
3.1M
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
FShannon
|
732 |
144K |
8 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
732
|
144K
|
8
|
|
ASX - By Stock
|
FGR |
Re:
Ann: Updated Corporate Presentation
|
|
FShannon
|
27 |
10K |
8 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
27
|
10K
|
8
|
|